CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 207 filers reported holding CARDLYTICS INC in Q1 2021. The put-call ratio across all filers is 1.12 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,338,883 | +143.8% | 1,050,841 | -6.6% | 0.04% | +150.0% |
| Q2 2023 | $7,112,472 | +111.7% | 1,125,391 | +13.9% | 0.01% | +100.0% |
| Q1 2023 | $3,360,329 | +165.4% | 988,332 | +351.2% | 0.01% | +133.3% |
| Q4 2022 | $1,266,080 | -36.4% | 219,045 | +3.5% | 0.00% | -25.0% |
| Q3 2022 | $1,990,000 | -51.4% | 211,696 | +15.2% | 0.00% | -50.0% |
| Q2 2022 | $4,097,000 | +199.9% | 183,728 | +789.2% | 0.01% | +166.7% |
| Q4 2021 | $1,366,000 | -91.4% | 20,662 | -83.6% | 0.00% | -95.8% |
| Q2 2021 | $15,946,000 | +77.9% | 125,630 | +53.8% | 0.07% | +75.6% |
| Q1 2021 | $8,961,000 | +176.3% | 81,680 | +259.6% | 0.04% | +127.8% |
| Q4 2020 | $3,243,000 | +382.6% | 22,717 | -44.1% | 0.02% | +500.0% |
| Q1 2019 | $672,000 | – | 40,658 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners VIII LLC | 1,133,141 | $29,439,000 | 58.62% |
| Polaris Venture Management Co. V, L.L.C. | 2,277,342 | $59,165,000 | 46.48% |
| CAS Investment Partners, LLC | 2,162,020 | $56,169,000 | 14.39% |
| Cannell Capital | 626,975 | $16,289,000 | 4.62% |
| Antipodean Advisors LLC | 142,358 | $3,698,000 | 4.50% |
| Shannon River Fund Management LLC | 344,230 | $8,943,000 | 1.42% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 19,048 | $495,000 | 1.40% |
| Tygh Capital Management, Inc. | 176,237 | $4,579,000 | 0.78% |
| Penn Capital Management Company, LLC | 263,499 | $6,846,000 | 0.68% |
| EAM Global Investors LLC | 56,866 | $1,477,000 | 0.63% |